DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

A recent cohort study suggests physical activity may improve psoriasis severity and cardiovascular health, showing reduced PASI scores and better BP.

Discover a recent study from 12 hospitals across China that has shed new light on personalised care for plaque psoriasis.

This included data from the phase 3 Opportuniti study (ClinicalTrials.gov Identifier: NCT04785326), which compared the biosimilar to Stelara in patients with moderate to severe chronic plaque ...

Psoriasis is a chronic autoimmune skin condition that causes patches of thick, red, scaly skin. Usually, the elbows, knees, ...

Most extensive LEO Pharma program to date at the European Academy of Dermatology and Venereology (EADV) congress featured an ...

Psoriasis is a chronic, recurrent, inflammatory and systemic disease ... In September 2024, the NMPA accepted the first NDA for picankibart for the treatment of moderate to severe plaque psoriasis.

Guttate psoriasis is a type of psoriasis characterized by the spontaneous eruption of small, teardrop-shaped skin lesions. In most cases, guttate psoriasis is triggered by group A Streptococcus (group ...

Stelara (ustekinumab) is a prescription injection that’s used to treat certain autoimmune conditions, such as plaque psoriasis ... If you have symptoms of a severe allergic reaction, such ...

Taltz (ixekizumab) is a prescription drug that treats certain autoimmune conditions, including plaque psoriasis. You will receive Taltz as an injection under your skin. It can interact with ...